ENDV Endonovo Therapeutics, Inc.

Fundamentals / CIK 0001528172 / USD

Endonovo Therapeutics, Inc. reported $256K in revenue and a net loss of $4.40M for the trailing twelve months ended September 30, 2023 (down 86.1% year over year), with a 96.2% gross margin and a -1023.2% operating margin.

Audited annual (10-K / 20-F) and quarterly (10-Q) statements parsed directly from SEC EDGAR CompanyFacts. Open ENDV in the Convexity terminal for live prices, valuation multiples, transcripts, and insider flow.

Annual revenue and net income

10 fiscal years (2013 to 2022), reported in USD.

$2.26M$1.13M$0-$17.30MFY 2013 Revenue: $23KFY 2013 Net Income: -$2.89M2013FY 2014 Revenue: $24KFY 2014 Net Income: -$959K2014FY 2015 Revenue: $4.3KFY 2015 Net Income: -$6.77M2015FY 2016 Net Income: -$5.32M2016FY 2017 Net Income: -$10.81M2017FY 2018 Revenue: $83KFY 2018 Net Income: -$6.44M2018FY 2019 Revenue: $310KFY 2019 Net Income: -$17.31M2019FY 2020 Revenue: $166KFY 2020 Net Income: -$396K2020FY 2021 Revenue: $73KFY 2021 Net Income: -$3.10M2021FY 2022 Revenue: $135KFY 2022 Net Income: -$18.47M2022

Financial statements and ratios

Reported in USD. Per-share figures and share counts are adjusted for stock splits from SEC filings.

Income Statement (Annual) · Reported in USD · Newest filing period first.

Income Statement Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Revenue $135K $73K $166K $310K $83K -- -- $4.3K $24K $23K
Cost of Revenue $10.0K $15K $65K $93K $13K -- -- $2.2K $15K $14K
Gross Profit $125K $58K $100K $217K $70K -- -- $2.1K $8.7K $8.9K
Research & Development -- $0 $3.3K $153K $274K $115K $0 -- -- --
Total Operating Expenses $3.39M $2.28M $3.01M $4.03M $4.23M $4.60M $5.41M $2.57M $2.20M $2.44M
Operating Income -$3.26M -$2.23M -$2.91M -$3.81M -$4.16M -$4.60M -$5.41M -$2.56M -$2.19M -$2.43M
EBITDA -$2.62M -$1.58M -$2.26M -$3.16M -$3.51M -$4.59M -$5.40M -$2.55M -$2.18M -$2.42M
Interest Expense -- $942K $2.08M $17K -- -- -- -- -- --
Income Before Tax -$18.47M -$3.10M -$396K -$17.31M -$6.44M -$10.81M -$5.32M -$6.77M -$959K -$2.89M
Income Tax Expense -- -- -- -- -- -- -- $0 $0 $532
Net Income -$18.47M -$3.10M -$396K -$17.31M -$6.44M -$10.81M -$5.32M -$6.77M -$959K -$2.89M
Basic EPS -$0.13 -$0.05 -$0.03 -$24.83 -$17.76 -$0.04 -$0.05 -$0.07 -$0.03 -$3.96
Diluted EPS -- -$0.05 -$0.03 -$24.83 -$17.76 -$0.04 -$0.05 -$0.07 -$0.03 -$3.96
Basic Shares Outstanding 139.2M 59.8M 12.2M 697.3K 362.5K 242.1M 117.4M 96.8M 30.3M 730.5K
Diluted Shares Outstanding -- 59.8M 12.2M 697.3K 362.5K 242.1M 117.4M 96.8M 30.3M 730.5K

Income Statement (Quarterly) · Reported in USD · Newest filing period first.

Income Statement 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31
Revenue $1.5K $45K $88K $121K $11K $650 $2.3K $316
Cost of Revenue $827 $0 $4.0K $4.9K $4.0K $383 $714 $8.9K
Gross Profit $693 $45K $84K $117K $6.9K $267 $1.6K -$8.5K
Research & Development -- -- -- -- -- -- -- $0
Total Operating Expenses $473K $1.18M $613K $600K $504K $1.80M $487K $365K
Operating Income -$473K -$1.13M -$529K -$483K -$497K -$1.80M -$486K -$374K
EBITDA -- -- -- -$321K -$335K -$1.64M -$324K -$212K
Income Before Tax -$766K $2.06M $7.23M -$12.93M -$603K -$2.53M -$2.41M $2.40M
Net Income -$766K $2.06M $7.23M -$12.93M -$603K -$2.53M -$2.41M $2.40M
Basic EPS -$0.00 $0.00 $0.03 -- $0.00 -$0.02 -$0.03 --
Diluted EPS $0.00 -$0.01 $0.00 -- $0.00 -$0.02 -$0.03 --
Basic Shares Outstanding 298.4M 276.3M 251.4M -- 153.6M 134.4M 79.0M --
Diluted Shares Outstanding 1.35B 1.35B 1.74B -- 153.6M 134.4M 79.0M --

Balance Sheet (Annual) · Reported in USD · Newest filing period first.

Balance Sheet Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Cash & Cash Equivalents $98 $86K $13K $19K $379K $90K $56K $41K $988 $3.3K
Cash & Short-Term Investments $98 $86K $13K $19K $379K $90K $56K $41K $988 $3.3K
Accounts Receivable, Net -- $944 $942 $23K $3.3K -- -- -- -- --
Other Current Assets -- -- -- -- -- -- -- $336K $2.0K --
Total Current Assets $16K $95K $46K $63K $382K $111K $303K $378K $3.0K $3.3K
Property, Plant & Equipment, Net -- -- $1.6K $5.9K $6.7K $1.1K $16K $32K $43K $58K
Goodwill -- -- -- -- -- -- -- -- -- $198K
Intangible Assets $1.27M $1.91M $2.56M $3.21M $3.85M $4.50M -- -- -- $12K
Total Non-Current Assets $1.27M $1.91M $2.56M $3.21M $3.86M $4.50M $16K $32K $43K $70K
Total Assets $1.28M $2.01M $2.61M $3.27M $4.24M $4.61M $319K $409K $46K $74K
Accounts Payable $884K $658K $701K $599K $157K $144K -- -- -- --
Short-Term Debt -- -- -- -- -- $4.2K $12K $12K $12K --
Total Current Liabilities $33.38M $17.70M $16.83M $23.62M $15.48M $13.41M $8.72M $9.49M $4.55M $4.01M
Long-Term Debt $7.15M $7.26M $6.84M $6.87M $8.16M $7.35M $3.18M $17K $1.56M --
Other Non-Current Liabilities $80K $80K -- -- -- -- -- -- -- --
Total Non-Current Liabilities $80K $80K $155K $155K $155K $753K $159K $199K $184K $197K
Total Liabilities $33.46M $17.78M $16.98M $23.78M $15.63M $14.16M $8.88M $9.69M $4.74M $4.21M
Total Debt (incl. Leases) $7.15M $7.26M $6.84M $6.87M $8.16M $7.36M $3.19M $29K $1.57M --
Common Stock $21K $7.4K $2.5K $118 $43 $32K $13K $10K $8.1K $832
Retained Earnings -$75.12M -$56.44M -$53.34M -$52.93M -$35.62M -$29.18M -$18.37M -$13.06M -$6.29M -$5.33M
Total Stockholders' Equity -$32.18M -$15.77M -$14.37M -$20.50M -$11.39M -$9.55M -$8.56M -$9.28M -$4.69M -$4.13M
Total Equity -$32.18M -$15.77M -$14.37M -$20.50M -$11.39M -$9.55M -$8.56M -$9.28M -$4.69M -$4.13M

Balance Sheet (Quarterly) · Reported in USD · Newest filing period first.

Balance Sheet 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31
Cash & Cash Equivalents $0 $33K $11K $98 $23K $0 $60K $86K
Cash & Short-Term Investments $0 $33K $11K $98 $23K $0 $60K $86K
Accounts Receivable, Net -- -- $3.1K -- $944 $945 $945 $944
Total Current Assets $36K $73K $95K $16K $24K $5.9K $64K $95K
Intangible Assets $780K $942K $1.10M $1.27M $1.43M $1.59M $1.75M $1.91M
Total Non-Current Assets $780K $942K $1.10M $1.27M $1.43M $1.59M $1.75M $1.91M
Total Assets $816K $1.01M $1.20M $1.28M $1.45M $1.59M $1.82M $2.01M
Accounts Payable -- -- -- $884K $866K $786K $704K $658K
Total Current Liabilities $23.70M $23.14M $25.49M $33.38M $20.98M $20.68M $19.77M $17.70M
Long-Term Debt $7.09M $7.05M $6.90M $7.15M $7.27M $7.41M $7.35M $7.26M
Other Non-Current Liabilities -- -- -- $80K -- -- -- $80K
Total Non-Current Liabilities $80K $80K $80K $80K $80K $80K $80K $80K
Total Liabilities $23.78M $23.22M $25.57M $33.46M $21.06M $20.75M $19.85M $17.78M
Total Debt (incl. Leases) $7.09M $7.05M $6.90M $7.15M $7.27M $7.41M $7.35M $7.26M
Common Stock $28K $28K $27K $21K $16K $15K $8.1K $7.4K
Retained Earnings -$66.63M -$65.86M -$67.93M -$75.12M -$61.99M -$61.38M -$58.86M -$56.44M
Total Stockholders' Equity -$22.96M -$22.41M -$24.37M -$32.18M -$19.61M -$19.16M -$18.04M -$15.77M
Total Equity -$22.96M -$22.41M -$24.37M -$32.18M -$19.61M -$19.16M -$18.04M -$15.77M

Cash Flow Statement (Annual) · Reported in USD · Newest filing period first.

Cash Flow Statement Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Net Income -$18.47M -$3.10M -$396K -$17.31M -$6.44M -$10.81M -$5.32M -$6.77M -$959K -$2.89M
Depreciation & Amortization $647K $648K $651K $650K $650K $15K $16K $15K $16K $12K
Stock-Based Compensation $45K $0 $57K $31K -- -- -- -- -- --
Change in Receivables -- -$2 $22K -$19K -$3.3K -- -- -- -- -$300
Change in Payables -- -$42K $94K $442K $63K -$112K -- -- -- --
Operating Cash Flow -$679K -$987K -$742K -$2.54M -$2.88M -$2.99M -$2.46M -$1.02M -$909K -$257K
Capital Expenditure -- -- -- -$2.6K -$9.0K -- -- -$3.8K $0 --
Free Cash Flow -- -- -- -$2.54M -$2.89M -- -- -$1.02M -$909K --
Acquisitions, Net -- -- -- -- -- -- -- -- -- $4.1K
Investing Cash Flow -- -- -- -$2.6K -$9.0K -$3.00M -- -$3.8K $0 $4.1K
Common Stock Issued $142K $126K $100K $168K $85K $1.29M $1.24M $139K $0 --
Financing Cash Flow $593K $1.06M $736K $2.18M $3.18M $6.02M $2.48M $1.06M $907K $256K
Net Change in Cash -$86K $73K -$5.5K -$360K $289K $35K $14K $40K -$2.3K $2.5K

Cash Flow Statement (Quarterly) · Reported in USD · Newest filing period first.

Cash Flow Statement 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31
Net Income -$766K $2.06M $7.23M -$12.93M -$603K -$2.53M -$2.41M $2.40M
Depreciation & Amortization -- -- -- $162K $162K $162K $162K $162K
Stock-Based Compensation $0 $3.4K $2.6K -- -- -- -- -$61K
Change in Receivables -- -- -$3.1K -- -- -- -- $6.1K
Change in Payables -- -- -- -- -- -- $46K -$95K
Operating Cash Flow -$65K -$166K -$173K -$226K -$124K -$206K -$123K -$391K
Common Stock Issued $3.8K $46K $207K -- -- -- -- $0
Financing Cash Flow $33K $188K $184K $202K $147K $146K $97K $472K
Net Change in Cash -$33K $22K $11K -$23K $23K -$60K -$26K $80K

Margins, returns, leverage, liquidity, and year-over-year growth computed directly from SEC EDGAR statement levels. Multi-year figures show cumulative per-share growth.

Ratios & Growth Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Gross Margin 92.6% 79.5% 60.6% 69.9% 84.5% -- -- 49.3% 36.0% 38.9%
Operating Margin -2411.7% -3045.7% -1756.5% -1228.1% -4995.3% -- -- -60132.7% -9057.6% -10607.6%
Net Profit Margin -13649.2% -4247.2% -238.6% -5582.4% -7729.5% -- -- -158633.9% -3966.2% -12634.5%
Return on Assets (ROA) -1441.9% -154.7% -15.2% -528.7% -151.7% -234.4% -1668.0% -1652.7% -2104.7% -3930.8%
Current Ratio 0.00x 0.01x 0.00x 0.00x 0.02x 0.01x 0.03x 0.04x 0.00x 0.00x
Quick Ratio 0.00x 0.00x 0.00x 0.00x 0.02x 0.01x 0.01x 0.00x 0.00x 0.00x
Revenue Growth (YoY) +85.2% -55.9% -46.5% +272.5% -- -- -- -82.4% +5.7% --
Gross Profit Growth (YoY) +115.7% -42.1% -53.7% +208.2% -- -- -- -75.8% -2.2% --
5Y Revenue / Share Growth -- -- +30718.2% +55588.8% +632.9% -- -- -99.6% -- --
10Y Revenue / Share Growth -- -87.8% +20.2% -- -- -- -- -- -- --

Quarterly margins, ROE, and ROA use trailing-twelve-month (TTM) flows summed across four contiguous quarters. Growth rates are true year-over-year comparisons against the same quarter a year earlier.

Ratios & Growth 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31
Gross Margin 96.2% 95.1% 94.0% 92.6% 1.6% -18.3% 67.6% 79.5%
Operating Margin -1023.2% -995.8% -1499.4% -2411.7% -22206.4% -30354.8% -5217.0% -3045.7%
Net Profit Margin -1722.2% -1599.5% -4003.0% -13649.2% -22145.1% -36842.6% -6975.9% -4247.2%
Return on Assets (ROA) -539.9% -417.9% -736.6% -1441.9% -216.8% -255.0% -156.3% -154.7%
Current Ratio 0.00x 0.00x 0.00x 0.00x 0.00x 0.00x 0.00x 0.01x
Quick Ratio 0.00x 0.00x 0.00x 0.00x 0.00x 0.00x 0.00x 0.00x
Revenue Growth (YoY) -86.1% +6853.8% +3736.1% +38337.7% +40.7% -97.9% -93.4% -97.3%
Gross Profit Growth (YoY) -90.0% +16828.8% +5228.1% -- +47.9% -99.1% -95.1% --
Net Income Growth (YoY) -- -- -- -639.7% -- -- -- --
Source: SEC EDGAR CompanyFacts (CIK 0001528172) · from December 31, 2010 Data through September 30, 2023 · synced Nov 21, 2026, 05:16 UTC · Open in terminal